preliminary results from the phase ii pioneer trial of t3d-959 in mild-moderate alzheimer’s disease
Published 2 years ago • 101 plays • Length 6:17Download video MP4
Download video MP3
Similar videos
-
6:34
phase iia exploratory trial of t3d-959 in mild-moderate alzheimer’s disease
-
7:49
targeting brain metabolism in alzheimer’s disease: results from the pioneer trial
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
1:38
ct1812: exciting preliminary results
-
18:06
phase ii/iii gain trial results: atuzaginstat for disease modification in alzheimer’s disease
-
4:21
phase ii trial of acu193 in alzheimer’s disease
-
2:05
phase ii clinical trial of sage-718 for the treatment of mci and early ad
-
1:27
uab involved in clinical trials for new fda-approved alzheimer's drug
-
2:46
phase ii/iii gain trial of a novel lysine-gingipain inhibitor for the treatment of alzheimer’s
-
2:39
drug to fight alzheimer's limited to those in clinical trials
-
1:04:51
denis smirnov - clinicopathologic studies of alzheimer's disease and related dementias
-
49:24
dr. jason karlawish - redefining alzheimer's disease: the role of clinical trials
-
1:00
alzheimer's clinical trial drug yields negative result
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
1:27:33
alzheimer's disease research update may 21, 2021
-
10:19
clinical trial for ban2401 in early alzheimer’s: combining adcoms and bayesian statistics
-
1:10:23
if you build it, will they come strategies for alzheimer’s disease clinical trial recruitment 201806
-
51:09
2016 updates on dementia: update on experimental therapeutic approaches
-
1:14
alzheimer's drug shows promise in early results of study